-
Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K.
Ultrasound Obstet Gynecol 2008;31:256-60. -
Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH.
Obstet Gynecol 2008;112:598-605. -
Nuchal translucency and the risk of congenital heart disease.
Hyett J, Sonek J, Nicolaides KH.
Obstet Gynecol 2007;109:1455-6. -
Outcome of antenatally diagnosed sacrococcygeal teratomas: single-center experience (1993-2004)
Makin EC, Hyett J, Ade-Ajayi N, Patel S, Nicolaides K, Davenport M.
J Pediatr Surg 2006;41:388-93. -
Current outcome of antenatally diagnosed exomphalos: an 11 year review.
Lakasing L, Cicero S, Davenport M, Patel S, Nicolaides KH.
J Pediatr Surg 2006;41:1403-6. -
Prenatal diagnosis for severe inherited skin disorders: 25 years' experience.
Fassihi H, Eady RA, Mellerio JE, Ashton GH, Dopping-Hepenstal PJ, Denyer JE, Nicolaides KH, Rodeck CH, McGrath JA.
Br J Dermatol 2006;154:106-13. -
Metopic suture in fetuses with Apert syndrome at 22-27 weeks of gestation.
Faro C, Chaoui R, Wegrzyn P, Levaillant JM, Benoit B, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:28-33. -
Definitive surgical management of antenatally diagnosed exomphalos.
Rijhwani A, Davenport M, Dawrant M, Dimitriou G, Patel S, Greenough A, Nicolaides K.
J Pediatr Surg 2005;40:516-22. -
Relation between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;26:154-7. -
Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops.
Hernandez-Andrade E, Scheier M, Dezerega V, Carmo A, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:442-5. -
Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation.
Souka AP, Krampl E, Geerts L, Nicolaides KH.
Prenat Diagn 2002;22:91-2. -
Hypophosphatasia associated with increased nuchal translucency: a report of two affected pregnancies.
Souka AP, Raymond FL, Mornet E, Geerts L, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:294-5. -
Blackfan-Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation.
Souka AP, Bower S, Geerts L, Huggon I, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:197-9. -
Prenatal ultrasound diagnosis of Leroy I cell disease.
Lees C, Homfray T, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:275-6. -
Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
Ghi T, Huggon IC, Zosmer N, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:610-4. -
Morbidity in infants with antenatally-diagnosed anterior abdominal wall defects.
Dimitriou G, Greenough A, Mantagos JS, Davenport M, Nicolaides KH.
Pediatr Surg Int 2000;16:404-7. -
Increased fetal nuchal translucency: possible association with esophageal atresia.
Brown RN, Nicolaides KH.
Ultrasound Obstet Gynecol 2000;15:531-2. -
Nuchal translucency as a marker of congenital heart disease.
Perdu M, Hyett JA, Sharland G, Snijders RS, Nicolaides KH.
Contracept Fertil Sex 1999;27:I-V. -
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:307-10. -
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH.
BMJ 1999;318:81-5.